cent) were successfully genotyped: HIV-1 subtype C was the most prevalent (97 per cent), followed by subtype A1 (1.2 per cent), mosaic recombinant forms (1.2 per cent), subtype G (0.5 per cent), and subtype D (0.2 per cent). Over 60 per cent of the children had at least one mutation associated to drug resistance to NRTI/NNRTI. As expected a high frequency of mutations to NNRT (52.9 per cent) in comparison to NRTIs (11.4 per cent) due to the low genetic barrier of this class of drugs was observed. For NNRTI, K103N, Y181C, E138A, and G190A were most common whereas for the NRTI, M184V was the most common. Maternal prophylaxis with HAART was significantly (P < 0.05, OR 2.41) associated with the emergence of drug resistance mutation to NRTI in HIV infected children. In conclusion, the high level of transmitted-resistant viruses observed in this study suggests that political strategies to enhance the level of adherence in maternal HAART should be taken into account. This is an important consideration due to the fact that Mozambique recently implemented the integrated PMTCT option Bþ approach. Low adherence in such a treatment context may undermine de efficacy of first-line option in the country. Continuing surveillance studies among HIV infected children remains critical to monitor the impact of PMTCT strategies. Furthermore, current results highlight the need to reinforce adherence counseling with appropriate follow up. HIV-1 subtype B appears to be the most genetically diverse AIDS virus in Haiti. However, there have been few phylogenetic analyses on circulating drug-resistant HIV-1 strains. The primary objective of this study is to analyze the patterns of genetic diversity of HIV-1 in Haiti and describe the molecular epidemiology of HIV-1 drug resistance (HIV-DR) in the population. HIV-1 genotyping was performed for HIV-positive patients who were either initiating or failing antiretroviral therapy from 2005 to 2010. The Stanford University Database (http://hivdb.stanford. edu/hiv) was used to analyze the protease-RT sequences for mutations associated with resistance to antiretroviral drugs. In the context of this course, the pol gene sequences obtained from these patients will be pooled in a database and used to perform the phylogenetic analyses. This study will provide a global view of HIV-1 genetic diversity and drug resistance strains circulating and transmitted within the country. Phylogenetic analysis of HIV-DR strains is absolutely necessary to monitor HIV-DR strain evolution, and will also contribute to strengthening the implementation of public health strategies to prevent and address the emergence of HIV-DR in Haiti.
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